CD19-B Cell Depletion in PAIS-ME/CFS Patients

Back to Post-acute Infectious Syndrome (PAIS) trials

Opening soon

Plain-English translation of NCT07724834 on ClinicalTrials.gov ↗ · Source last updated July 2026 · How we translate trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(1 site)

Germany

Charité - Universitätsmedizin Berlin, Berlin

Key details

Phase

Testing effectiveness

Sponsor

Charite University, Berlin, Germany

Enrollment target

~38 participants

Started

December 2026

Primary completion

February 2029

Age range

18 Years – 65 Years

Last updated on clinicaltrials.gov in July 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Judith Bellmann-Strobl, MD

Charité - Universitätsmedizin Berlin, Berlin, Germany 10117

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

View full record on ClinicalTrials.gov